ATE309254T1 - Gewebespezifische fluoreszierende chelate - Google Patents

Gewebespezifische fluoreszierende chelate

Info

Publication number
ATE309254T1
ATE309254T1 AT02773911T AT02773911T ATE309254T1 AT E309254 T1 ATE309254 T1 AT E309254T1 AT 02773911 T AT02773911 T AT 02773911T AT 02773911 T AT02773911 T AT 02773911T AT E309254 T1 ATE309254 T1 AT E309254T1
Authority
AT
Austria
Prior art keywords
tissue
chelates
specific fluorescent
fluorescent chelates
fluorescent
Prior art date
Application number
AT02773911T
Other languages
German (de)
English (en)
Inventor
Garry E Kiefer
Darryl J Bornhop
Original Assignee
Univ Texas Tech
Dow Global Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas Tech, Dow Global Technologies Inc filed Critical Univ Texas Tech
Application granted granted Critical
Publication of ATE309254T1 publication Critical patent/ATE309254T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02773911T 2001-10-22 2002-10-22 Gewebespezifische fluoreszierende chelate ATE309254T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35568401P 2001-10-22 2001-10-22
PCT/US2002/034242 WO2003035655A1 (en) 2001-10-22 2002-10-22 Tissue specific fluorescent chelates

Publications (1)

Publication Number Publication Date
ATE309254T1 true ATE309254T1 (de) 2005-11-15

Family

ID=23398394

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02773911T ATE309254T1 (de) 2001-10-22 2002-10-22 Gewebespezifische fluoreszierende chelate

Country Status (6)

Country Link
US (1) US6962690B2 (cg-RX-API-DMAC7.html)
EP (1) EP1438318B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005507005A (cg-RX-API-DMAC7.html)
AT (1) ATE309254T1 (cg-RX-API-DMAC7.html)
DE (1) DE60207288T2 (cg-RX-API-DMAC7.html)
WO (1) WO2003035655A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049096A2 (en) * 2003-11-14 2005-06-02 Dow Global Technologies Inc. Protein and polymer conjugates as chelants with enhanced blood retention
DE102004022628A1 (de) * 2004-05-07 2005-12-15 Sensient Imaging Technologies Gmbh FRET-Bioassay
US20060210479A1 (en) * 2004-08-10 2006-09-21 Dow Global Technologies Inc. Targeting chelants and chelates
WO2006026038A1 (en) * 2004-08-26 2006-03-09 Mallinckrodt Inc. Luminescent metal complexes for monitoring renal function
EP1885817B1 (en) * 2005-05-11 2016-05-11 University Of Durham Responsive luminescent lanthanide complexes
DK1885817T3 (en) 2005-05-11 2016-08-22 Univ Durham Luminescent lanthanide OF RESPONSE
GB0613823D0 (en) 2006-07-12 2006-08-23 Univ Durham Assay
US7996068B2 (en) * 2007-03-14 2011-08-09 The Board Of Trustees Of The Leland Stanford Junior University Surgical method and apparatus for identification of fluorescence
WO2009039466A1 (en) 2007-09-20 2009-03-26 Vanderbilt University Free solution measurement of molecular interactions by backscattering interferometry
US20100036260A1 (en) 2008-08-07 2010-02-11 Remicalm Llc Oral cancer screening device
WO2011156713A1 (en) 2010-06-11 2011-12-15 Vanderbilt University Multiplexed interferometric detection system and method
US9562853B2 (en) 2011-02-22 2017-02-07 Vanderbilt University Nonaqueous backscattering interferometric methods
US9273949B2 (en) 2012-05-11 2016-03-01 Vanderbilt University Backscattering interferometric methods
WO2016118812A1 (en) 2015-01-23 2016-07-28 Vanderbilt University A robust interferometer and methods of using same
EP3408649B1 (en) 2016-01-29 2023-06-14 Vanderbilt University Free-solution response function interferometry

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8502573D0 (sv) 1985-05-23 1985-05-23 Jouko Kanakre Fluorescent lanthanide chelates useful as labels of physiologically active materials
US4976950A (en) 1988-12-19 1990-12-11 The Dow Chemical Company Bone marrow suppressing agents
US5312922A (en) 1992-04-06 1994-05-17 Nordion International Inc. Europium and terbium chelators for time-resolved fluorometric assays
US5714604A (en) 1993-05-06 1998-02-03 The Dow Chemical Company Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives
US5462725A (en) * 1993-05-06 1995-10-31 The Dow Chemical Company 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
ATE254129T1 (de) 1996-04-19 2003-11-15 Dow Global Technologies Inc Fluoreszierende chelate als gewebespezifische bildgebende mittel
WO2003020701A2 (en) * 2001-09-04 2003-03-13 Texas Tech University Multi-use multimodal imaging chelates

Also Published As

Publication number Publication date
US20030099598A1 (en) 2003-05-29
WO2003035655A1 (en) 2003-05-01
US6962690B2 (en) 2005-11-08
EP1438318B1 (en) 2005-11-09
JP2005507005A (ja) 2005-03-10
DE60207288D1 (de) 2005-12-15
DE60207288T2 (de) 2006-05-18
EP1438318A1 (en) 2004-07-21

Similar Documents

Publication Publication Date Title
DE69726135D1 (de) Fluoreszierende chelate als gewebespezifische bildgebende mittel
DE60207288D1 (de) Gewebespezifische fluoreszierende chelate
AU2002339865A1 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
IL180896A0 (en) Method of tumour imaging
AU3983201A (en) Compositions and methods for the early diagnosis of ovarian cancer
AU3491001A (en) Compositions and methods for the early diagnosis of ovarian cancer
WO2002080754A3 (en) Methods for using annexin for detecting cell death in vivo and treating associated conditions
AU2001256973A1 (en) Diffusion imaging of tissues
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2003300368A8 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
DE60223176D1 (de) Metallkomplexverbindungen
AU2002246519A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003237792A8 (en) Compositions and methods for the diagnosis and treatment of tumor
ATE366936T1 (de) Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
EP1349485A4 (en) COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAL CARCINOMA
AU3483001A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
HUP0200825A2 (en) Compositions and methods for the treatment and diagnosis of breast cancer
ZA200108256B (en) Compositions and methods for the treatment and diagnosis of breast cancer.
IL148342A0 (en) Methylenen blue diagnostic agent and diagnostic methods for detection of epithelial cancer
AU2001294165A1 (en) Apparatus for prostate cancer diagnose
WO2005115105A3 (en) Self-immolative magnetic resonance imaging contrast agents sensitive to beta-glucuronidase
PL365279A1 (en) Biotin-derivates and their conjugates with chelating agents
DE60136706D1 (de) Ycin-acryloyl derivate und antimetabolische mitteln
IL145589A0 (en) In vivo stain compounds and methods of use to identify dysplastic tissue

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties